Scientists Develop Universal Vaccine for Winter Infections

Got story updates? Submit your updates here. ›

Scientists at Stanford University have announced they have created a universal vaccine that could protect against a wide range of common winter infections, including the common cold, flu, COVID-19, and bacterial pneumonia. The new vaccine takes a radical departure from traditional single-disease vaccines, instead training the immune system to fight multiple respiratory threats.

Why it matters

If successful, this universal vaccine could revolutionize how we approach seasonal illnesses, potentially reducing the burden on healthcare systems and allowing people to better maintain their health during the winter months.

The details

The team at Stanford has tested the vaccine in animal trials, but it still needs to go through clinical trials in humans before it can be approved for use. The scientists say their approach involves training the immune system to fight a broader range of pathogens, rather than just targeting a single disease like existing vaccines.

• The vaccine has been tested in animal trials.
• The researchers expect the vaccine could be used in practice in 5-7 years if clinical trials are successful.

What’s next

The vaccine still needs to undergo clinical trials in humans before it can be approved for use.